Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, December 7, 2023
Courthouse News Service
Thursday, December 7, 2023 | Back issues
Courthouse News Service Courthouse News Service

Drug Firm Claims Poor Legal Work|Cost It $216 Million In Antitrust Problems

LOS ANGELES (CN) - Mylan Pharmaceuticals claims poor legal work on antitrust issues by attorneys with Ervin, Cohen & Jessupcost it $216 million. The issues involved deal with generic drug supplier Profarmaco that raised the prices of lorazepam and clorazepate by 1,900 to 3,200 percent, leading to an FTC investigation. Mylan is represented in Superior Court by Parker Mills Morin.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.